International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project
A legfontosabb adatok
- Hol
- Boston, Charlottesville, Dallas, Indianapolis és New Orleans (Egyesült Államok)Mind a 5 helyszín megnézése
Helyszínek itt: Egyesült Államok
- Massachusetts General HospitalBoston, Egyesült ÁllamokNo longer taking part
- University of VirginiaCharlottesville, Egyesült ÁllamokNo longer taking part
- Baylor University Medical CenterDallas, Egyesült ÁllamokNo longer taking part
- Indiana UniversityIndianapolis, Egyesült ÁllamokNo longer taking part
- Ochsner Medical CenterNew Orleans, Egyesült ÁllamokNo longer taking part
A vizsgálat adatai
- Ki végzi
- Azienda Ospedaliera di Padova
- Azonosító
- NCT05387811
- A regiszteradat frissítve
- 2024. január 30.
- Eredeti leírás
The aims of this study will be to identify the clinical characteristics, the management and the outcomes of acute kidney injury in patients with cirrhosis worldwide.A teljes eredeti leírásKevesebb
Characteristics and Management of Acute Kidney Injury in Hospitalized Patients With Cirrhosis: a Multicenter Intercontinental Observational Prospective Study: The International Club of Ascites GLOBAL AKI Project
The aims of this study will be to identify the clinical characteristics, the management and the outcomes of acute kidney injury in patients with cirrhosis worldwide.
Specific aims:
1. To establish the severity of AKI across different regions 2. To identify precipitants of AKI across different centers 3. To identify the phenotypes of AKI across different centers 4. To evaluate differences in the management of AKI across different centers and their impact on clinical outcomes 5. To assess outcomes of acute kidney injury (resolution of AKI, in-hospital mortality, 28-day mortality, 90-day mortality)
Bevonási feltételek: Patients with cirrhosis admitted to hospital for the treatment of a complication of liver disease (ascites, gastrointestinal bleeding, hepatic encephalopathy, bacterial infections, jaundice, etc).
Kizáró feltételek: Previously known severe extrahepatic diseases (e.g., chronic renal failure requiring hemodialysis, severe congestive heart disease [NYHA class ≥ 3]; severe chronic obstructive pulmonary disease [GOLD class ≥ 3], psychiatric disorders); Previous solid organ transplantation; Patients who cannot provide prior informed consent and no legal surrogate decision maker; Extrahepatic malignancy other than non-melanoma skin cancer within last 5 years; HIV infection with CD4 ≤ 250/µL; Age < 18 years old; Pregnancy; Hepatocellular carcinoma outside Milan criteria (i.e., a single lesion <5 cm or multiple lesions [maximum of three], the largest of which measures ≤ 3 cm).